Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
Sarwish Rafiq, Oladapo O. Yeku, Hollie J. Jackson, et al.
Nature Biotechnology (2018) Vol. 36, Iss. 9, pp. 847-856
Open Access | Times Cited: 678

Showing 1-25 of 678 citing articles:

A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman, Jill M. Fritz, Michael J. Lenardo
Nature reviews. Immunology (2020) Vol. 20, Iss. 11, pp. 651-668
Open Access | Times Cited: 3194
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq, Christopher S. Hackett, Renier J. Brentjens
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 3, pp. 147-167
Open Access | Times Cited: 1123
‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
Stéphane Depil, Philippe Duchâteau, Stephan A. Grupp, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 185-199
Open Access | Times Cited: 878
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Ming Yi, Xiaoli Zheng, Mengke Niu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 835
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
Marina C. Martinez, Edmund K. Moon
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 732
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Rebecca C. Larson, Marcela V. Maus
Nature reviews. Cancer (2021) Vol. 21, Iss. 3, pp. 145-161
Open Access | Times Cited: 633
CAR-NK cells: A promising cellular immunotherapy for cancer
Guozhu Xie, Han Dong, Yong Liang, et al.
EBioMedicine (2020) Vol. 59, pp. 102975-102975
Open Access | Times Cited: 606
Cancer immunotherapy: Pros, cons and beyond
Shuzhen Tan, Dongpei Li, Xiao Zhu
Biomedicine & Pharmacotherapy (2020) Vol. 124, pp. 109821-109821
Open Access | Times Cited: 543
Advances in cancer immunotherapy 2019 – latest trends
Stephan Krüger, Matthias Ilmer, Sebastian Kobold, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 500
Clinical implications of T cell exhaustion for cancer immunotherapy
Andrew Chow, Karlo Perica, Christopher A. Klebanoff, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 12, pp. 775-790
Open Access | Times Cited: 492
Engineering CAR-T Cells for Next-Generation Cancer Therapy
Mihe Hong, Justin Clubb, Yvonne Y. Chen
Cancer Cell (2020) Vol. 38, Iss. 4, pp. 473-488
Open Access | Times Cited: 482
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
Bryan D. Choi, Xiaoling Yu, Ana P. Castaño, et al.
Nature Biotechnology (2019) Vol. 37, Iss. 9, pp. 1049-1058
Closed Access | Times Cited: 449
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Mohamed-Reda Benmebarek, Clara H. Karches, Bruno L. Cadilha, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1283-1283
Open Access | Times Cited: 416
Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors
Rachel Grosser, Leonid Cherkassky, Navin K. Chintala, et al.
Cancer Cell (2019) Vol. 36, Iss. 5, pp. 471-482
Open Access | Times Cited: 405
Navigating CAR-T cells through the solid-tumour microenvironment
Andrew J. Hou, Laurence C. Chen, Yvonne Y. Chen
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 531-550
Open Access | Times Cited: 366
The Emerging Landscape of Immune Cell Therapies
Evan W. Weber, Marcela V. Maus, Crystal L. Mackall
Cell (2020) Vol. 181, Iss. 1, pp. 46-62
Open Access | Times Cited: 361
CAR immune cells: design principles, resistance and the next generation
Louai Labanieh, Crystal L. Mackall
Nature (2023) Vol. 614, Iss. 7949, pp. 635-648
Closed Access | Times Cited: 336
Enhancing anti-tumour efficacy with immunotherapy combinations
Funda Meric‐Bernstam, James Larkin, Josep Tabernero, et al.
The Lancet (2020) Vol. 397, Iss. 10278, pp. 1010-1022
Closed Access | Times Cited: 305
Recent advances in CAR-T cell engineering
Ruihao Huang, Xiaoping Li, Yundi He, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 297
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Meng‐Ling Wu, Qianrui Huang, Yao Xie, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 296
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.
Molecular Therapy (2020) Vol. 28, Iss. 11, pp. 2320-2339
Open Access | Times Cited: 293
CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma
Kai Rejeski, Ariel Perez Perez, Pierre Sesques, et al.
Blood (2021) Vol. 138, Iss. 24, pp. 2499-2513
Open Access | Times Cited: 291
T Cell Dysfunction in Cancer Immunity and Immunotherapy
Anliang Xia, Yan Zhang, Xu Jiang, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 290
CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
Karama Makni‐Maalej, Maysaloun Merhi, Varghese Inchakalody, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 284
CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
Linchun Jin, Haipeng Tao, Aida Karachi, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 282
Page 1 - Next Page

Scroll to top